IMMUNOFORGE
ImmunoForge is a developer of a new drug intended for treating sarcopenia and cancer. The company has a solution for sarcopenia based on its drug repurposing patents as well as a strong kinase inhibitor pipeline for genomically defined rare cancers, such as chronic myelogenous leukemia, enabling patients to get cured quickly.
IMMUNOFORGE
Industry:
Biotechnology Health Care Therapeutics
Founded:
2017-05-29
Address:
Seoul, Seoul-t'ukpyolsi, South Korea
Country:
South Korea
Website Url:
http://www.immunoforge.com
Total Employee:
11+
Status:
Active
Contact:
+82-70-7721-0755
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Font Awesome Apache Mobile Non Scaleable Content Google Apps For Business Sectigo SSL Sectigo Domain SSL
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
RightAir
RightAir is developing noninvasive ventilators for COPD patients.
Spinogenix
Spinogenix is a developer of a new class of therapeutics for neurodegenerative and psychiatric diseases.
Current Employees Featured
Founder
Investors List
Quantum Ventures Korea
Quantum Ventures Korea investment in Venture Round - ImmunoForge
Official Site Inspections
http://www.immunoforge.com
- Host name: 183.111.169.45
- IP address: 183.111.169.45
- Location: South Korea
- Latitude: 37.5112
- Longitude: 126.9741
- Timezone: Asia/Seoul
